Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported negative sales was KRW 0.00024 million compared to sales of KRW 0.00029 million a year ago. Net income was KRW 1,290.13 million compared to KRW 6,875.38 million a year ago.

Basic earnings per share from continuing operations was KRW 114 compared to KRW 604 a year ago. Diluted earnings per share from continuing operations was KRW 114 compared to KRW 604 a year ago. Basic earnings per share was KRW 114 compared to KRW 604 a year ago.